1. Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages
   Cong-hui Li et al, 2017, European Journal of Pharmacology CrossRef
2. Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease
   Weijia Yang et al, 2019, Journal of International Medical Research CrossRef
3. Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro
   Chen Gao et al, 2017, Molecular Medicine Reports CrossRef
4. Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota
   Yi Guo et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
5. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats
   Xin Tian et al, 2019, Journal of Pharmacy and Pharmacology CrossRef
6. Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects
   Qichao Hu et al, 2021, Pharmacological Research CrossRef
7. The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats
   Hossein Nikroo et al, 2020, Physiology & Behavior CrossRef
8. Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways
   Xueqing Zhong et al, 2018, Biomedicine & Pharmacotherapy CrossRef
9. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats
   Huanhuan Liu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
10. Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis
    Yi Chen et al, 2023, Biochemical Pharmacology CrossRef
11. Baicalin Attenuates Oxidative Stress in a Tissue-Engineered Liver Model of NAFLD by Scavenging Reactive Oxygen Species
    Wen Gao et al, 2022, Nutrients CrossRef
12. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
    Inés Mármol et al, 2017, International Journal of Molecular Sciences CrossRef
13. A Single Dose of Baicalin Has No Clinically Significant Effect on the Pharmacokinetics of Cyclosporine A in Healthy Chinese Volunteers
    Ruijuan Liu et al, 2019, Frontiers in Pharmacology CrossRef
14. Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments
    Ayesheh Enayati et al, 2022, PPAR Research CrossRef
15. Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats
    Yifei Shen et al, 2024, Toxicology Letters CrossRef
16. Nuclear receptors and nonalcoholic fatty liver disease
    Matthew C. Cave et al, 2016, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
17. Puerarin inhibits apoptosis and inflammation in myocardial cells via PPARα expression in rats with chronic heart failure
    Le He et al, 2019, Experimental and Therapeutic Medicine CrossRef
18. Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury
    Bu-Gao Zhou et al, 2018, Frontiers in Pharmacology CrossRef
19. Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review
    Risha Ganguly et al, 2022, World Journal of Gastroenterology CrossRef
20. Puerarin enhance vascular proliferation and halt apoptosis in thiram-induced avian tibial dyschondroplasia by regulating HIF-1α, TIMP-3 and BCL-2 expressions
    Muhammad Waqas et al, 2020, Ecotoxicology and Environmental Safety CrossRef
21. Baicalin and its aglycone: a novel approach for treatment of metabolic disorders
    Penghua Fang et al, 2020, Pharmacological Reports CrossRef
22. Upregulation of UDP-Glucuronosyltransferases 1a1 and 1a7 Are Involved in Altered Puerarin Pharmacokinetics in Type II Diabetic Rats
    Songtao Dong et al, 2018, Molecules CrossRef
23. Baicalin ameliorates high fat diet‐induced nonalcoholic fatty liver disease in mice via adenosine monophosphate‐activated protein kinase‐mediated regulation of SREBP1/Nrf2/NF‐κB signaling pathways
    Yanxia Gao et al, 2023, Phytotherapy Research CrossRef
24. Add-on therapy with traditional Chinese medicine: An efficacious approach for lipid metabolism disorders
    Ying Zhang et al, 2018, Pharmacological Research CrossRef
25. Protective effect of isoflavones and triterpenoid saponins from pueraria lobata on liver diseases: A review
    Heng He et al, 2022, Food Science & Nutrition CrossRef
26. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway
    Penghua Fang et al, 2019, Phytomedicine CrossRef
27. Molecular updates on berberine in liver diseases: Bench to bedside
    Sapana Bansod et al, 2021, Phytotherapy Research CrossRef
28. Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease—Clinical and Pre-Clinical Overview and Systematic Review of the Literature
    Florentina Ionita-Radu et al, 2024, International Journal of Molecular Sciences CrossRef